g agents will provide pharmaceutical researchers and clinicians with powerful tools for more precise monitoring and tracking of drug action in real-time," said Prasad.
The multimodal platforms underway in Prasad's group are based on versatile nanoparticles that the UB researchers have developed with previous Oishei Foundation funding that have been shown to be effective in a broad range of therapeutic applications.
"The fields of nanomedicine in which Dr. Prasad and his teams are working are developing extremely rapidly, and they are at the forefront," said Thomas E. Baker, president of the foundation. "The work of these grants has tremendous potential for significantly improving both the diagnostic capabilities of physicians and the clinical outcomes of patients."
The research also is being conducted with partial funding from UB's New York State Center of Excellence in Bioinformatics and Life Sciences, a major supporter of the nanomedicine program at the Institute for Lasers, Photonics and Biophotoncs. Prasad is affiliated with the Bioengineering/Tissue Engineering Team at the Center of Excellence.
"This new imaging work represents an exciting and timely extension of our existing nanomedicine portfolio that will be particularly important for the Center of Excellence initiatives in neurodegenerative disease and cancer," said Bruce A. Holm, UB senior vice provost and executive director of the Center of Excellence. "This research not only crosses a variety of UB 2020 Strategic Strength areas, but holds enormous promise for commercialization potential as well."
The UB institute's new emphasis on application of nanobiotechnology to medical imaging also distinguishes it from other nanotechnology research centers throughout the U.S., while enriching its current collaborations with The Johns Hopkins University, Roswell Park Cancer Institute and others.
The nanoprobes are being developed for use with: <Page: 1 2 3 Related medicine news :1
. Hybrid antibodies to protect from small pox infection2
. NHS To Be Reformed By Using A Hybrid Approach3
. Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced4
. Hybrid Molecule Causes Cancer Cells to Self-Destruct5
. Gold Nanoparticles: Agents For Noninvasive Cancer Therapy6
. Alzheimers Can Be Slowed Down By Gold Nanoparticles7
. Gold Nanoparticles Are Good Detectors Biological Toxins8
. Scientists To Study Effect Of Nanoparticles On Liver9
. Nanoparticles and Their Damage to Liver Cells10
. Effect of Nanoparticles on Liver11
. Use of Nanoparticles in Sunscreen under Scrutiny